2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
Porta C, Bamias A, Danesh F, Dębska-Ślizień A, Gallieni M, Gertz M, Kielstein J, Tesarova P, Wong G, Cheung M, Wheeler D, Winkelmayer W, Małyszko J, Participants C, Abu-Alfa A, Amer H, Beutel G, Chapman J, Chen X, Chudek J, Cosmai L, Danesi R, De Stefano F, Iseki K, Jaimes E, Jhaveri K, Jurczyszyn A, Kazancioğlu R, Kitchlu A, Kollmannsberger C, Lahoti A, Li Y, Macía M, Matsubara T, Mitropoulos D, Noiri E, Perazella M, Ronco P, Rosner M, Romeo M, Sprangers B, Stadler W, Stevens P, Tesař L, da Costa e Silva V, Vesole D, Vijayan A, Viklický O, Workeneh B, Yanagita M, Zakharova E. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer. Kidney International 2020, 98: 1108-1119. PMID: 33126977, DOI: 10.1016/j.kint.2020.06.046.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsChronic kidney diseaseSolid organ malignanciesControversies ConferenceKidney impairmentKidney diseaseKidney cancerKDIGO Controversies ConferenceSetting of malignancyIncidence of cancerAreas of controversyOrgan malignanciesTreatment landscapeKidney functionOncology patientsMedical oncologyPalliative careRenal issuesPatient outcomesNovel therapiesCritical careMalignancyAnticancer treatmentCancerPatientsCancer treatment
2019
Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis
Jubber I, Shariat S, Conroy S, Tan W, Gordon P, Lotan Y, Messing E, Stenzl A, Rhijn B, Kelly J, Catto J, Cumberbatch M. Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. European Urology 2019, 77: 583-598. PMID: 31791622, DOI: 10.1016/j.eururo.2019.10.010.Peer-Reviewed Original ResearchConceptsNon-visible haematuriaUpper tract urothelial carcinomaMeta-analysisSystematic reviewKidney cancerSystematic review of original articlesUrological cancersRisk of cancerIncidence of cancerReview of original articlesCancer detection rateRe-evaluation of patientsPublic health implicationsBladder cancerNarrative synthesisDiagnosis of BCInclusion criteriaMeta-analysesCigarette smokingHealth implicationsDiagnosis of bladder cancerMale sexEstimated riskHigh-risk patientsGroup of individuals
2018
Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients
Tan W, Feber A, Sarpong R, Khetrapal P, Rodney S, Jalil R, Mostafid H, Cresswell J, Hicks J, Rane A, Henderson A, Watson D, Cherian J, Williams N, Brew-Graves C, Kelly J, collaborators O. Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients. European Urology 2018, 74: 10-14. PMID: 29653885, DOI: 10.1016/j.eururo.2018.03.008.Peer-Reviewed Original ResearchConceptsUrinary tract cancerIncidence of urinary tract cancerInvestigation of haematuriaRisk of urinary tract cancerClinically significant cancerDiagnosis of urinary tract cancerHigh-risk cancerProspective observational studyIncidence of cancerSignificant cancerAge thresholdBladder cancerSmoking historyVisible bloodOlder patientsHaematuriaMale genderConsensus recommendationsPatientsObservational studyCancerPatient preferencesCancer diagnosisLack of consensusAge
2014
The role of vitamin D in reducing cancer risk and progression
Feldman D, Krishnan A, Swami S, Giovannucci E, Feldman B. The role of vitamin D in reducing cancer risk and progression. Nature Reviews Cancer 2014, 14: 342-357. PMID: 24705652, DOI: 10.1038/nrc3691.Peer-Reviewed Original ResearchMeSH Keywords25-Hydroxyvitamin D3 1-alpha-HydroxylaseBreast NeoplasmsCalcitriolCholecalciferolColonic NeoplasmsDisease ProgressionEndocrine SystemFemaleHumansMaleNeoplasmsNeoplastic Stem CellsPolymorphism, GeneticPrognosisProstatic NeoplasmsRandomized Controlled Trials as TopicRiskSignal TransductionSteroid HydroxylasesVitamin DVitamin D DeficiencyVitamin D3 24-HydroxylaseConceptsVitamin D receptorReduce cancer riskCancer riskRandomized Controlled TrialsCancer developmentVitamin D3Vitamin DLow levels of circulating 25(OH)DLevels of circulating 25(OH)DAssociated with increased incidence of cancerCancer stem cell biologySingle nucleotide polymorphismsRisk of cancer developmentAnimal models of cancerAssociated with increased incidenceVitamin D deficiencyVitamin D supplementationLevels of calcitriolSteroid hormone calcitriolHuman clinical trialsRetarding cancer developmentModels of cancerStem cell biologyIncidence of cancerDietary vitamin D3
1997
The Significance of Intraluminal Crystalloids in Benign Prostatic Glands on Needle Biopsy
Henneberry J, Kahane H, Humphrey P, Keetch D, Epstein J. The Significance of Intraluminal Crystalloids in Benign Prostatic Glands on Needle Biopsy. The American Journal Of Surgical Pathology 1997, 21: 725-728. PMID: 9199652, DOI: 10.1097/00000478-199706000-00014.Peer-Reviewed Original ResearchConceptsHigh-grade prostatic intraepithelial neoplasiaProstatic intraepithelial neoplasiaRepeat biopsyNeedle biopsyBenign glandsIntraluminal crystalloidsIntraepithelial neoplasiaBiopsy resultsSerum prostatic specific antigen (PSA) levelsSerum prostate-specific antigen valuesProstatic-specific antigen levelProstate-specific antigen valuesConsecutive needle biopsiesSpecific antigen levelsBenign prostatic glandsIncidence of cancerJohns Hopkins HospitalProstate biopsy resultsDianon SystemsConcurrent carcinomaSubsequent biopsyFirst biopsyAntigen levelsCystoprostatectomy specimensAntigen values
1995
Prevalence of Human Papillomavirus Among STD Clinic Attenders in Jamaica
FIGUEROA J, WARD E, LUTHI T, VERMUND S, BRATHWAITE A, BURK R. Prevalence of Human Papillomavirus Among STD Clinic Attenders in Jamaica. Sexually Transmitted Diseases 1995, 22: 114-118. PMID: 7624812, DOI: 10.1097/00007435-199503000-00007.Peer-Reviewed Original ResearchConceptsHuman papillomavirus infectionHuman papillomavirusPapillomavirus infectionSTD clinicOlder womenHigh HPV prevalenceHuman papillomavirus (HPV) prevalencePrevalence of HPVSTD clinic attendersIncidence of cancerMajor etiologic agentHuman papillomavirus (HPV) genomeLow-stringency Southern blot hybridizationCross-sectional surveyHPV prevalenceEffect of ageClinic attendersCervical cancerWomen 25Risk factorsWomen 20Effective vaccineLow prevalenceWomen 15Etiologic agent
1988
DIETARY FACTORS AND THE INCIDENCE OF CANCER OF THE URINARY BLADDER
RISCH H, BURCH J, MILLER A, HILL G, STEELE R, HOWE G. DIETARY FACTORS AND THE INCIDENCE OF CANCER OF THE URINARY BLADDER. American Journal Of Epidemiology 1988, 127: 1179-1191. PMID: 3369417, DOI: 10.1093/oxfordjournals.aje.a114911.Peer-Reviewed Original ResearchConceptsBladder cancerDietary factorsLow-calorie foodsConditional logistic regression methodsCalorie foodsIntake of cholesterolCase-control studyAge 20 yearsLife-style factorsIncidence of cancerHistory of exposureLack of associationOdds ratio estimatesArtificial sweetenersArea of residenceAverage daily intakeDiabetes mellitusCigarette smokingSubsequent riskCancer casesUrinary bladderRelevant food itemsMild increaseCancerDaily intake
1985
DIETARY FACTORS AND THE INCIDENCE OF CANCER OF THE STOMACH
RISCH H, JAIN M, CHOI N, FODOR J, PFEIFFER C, HOWE G, HARRISON L, CRAIB K, MILLER A. DIETARY FACTORS AND THE INCIDENCE OF CANCER OF THE STOMACH. American Journal Of Epidemiology 1985, 122: 947-959. PMID: 2998182, DOI: 10.1093/oxfordjournals.aje.a114199.Peer-Reviewed Original ResearchConceptsOdds ratio estimatesStomach cancerConditional logistic regression methodsVitamin C intakeCitrus fruit intakeCase-control studyIncidence of cancerArea of residenceAverage daily intakeC intakeFruit intakeRatio estimatesDietary factorsAverage daily consumptionCancer casesGastric cancerVitamin EDaily intakeCancerDietary componentsDaily consumptionLogistic regression methodIntakePopulation controlsDietary fiber
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply